healthcare innovation

The business case for integrating claims and clinical data

September 16, 2019
0
Category:
- Latest News
Tags: abbott labs accelerator advanced cellular technology amyotrophic lateral sclerosis Business cambridge cancer case certified emr China Claims Clinical Data DC dealflow diabetes diagnostic platforms diagnostics company Doctors EHR electronic health records electronic medical records embryonic stem cells employee wellness programs emr foodborne pathogens geron corporation health and wellness healthcare innovation healthcare it healthways hospitals humira integrating investing laser surgery life sciences lou gehrig Massachusetts md anderson cancer center mdt medcity news medical devices medtronic minimally invasive surgery minneapolis Minnesota motion sensors obesity overweight patient monitoring system pharmaceuticals publics RD renal denervation rock health San Francisco shanghai innovation center skin disorders St Jude Medical startup advice startup funding startups stj texas twin cities Ulcerative Colitis Washington weight loss wellness wellpoint

By partnering with a smart, secure, and collaborative health data network, providers and health plans can access integrated claims and clinical data and more effectively transition to value-based care. Source link

Sanofi’s billion-dollar multiple sclerosis drug faces competitive threat from Novartis, J&J agents

On Friday, Novartis presented data at ECTRIMS showing that Arzerra had superior efficacy to Sanofi’s Aubagio. Johnson & Johnson’s Janssen division had presented data for its drug, ponesimod, two days...

You are where you work

Moving away from the sick care toward primary care is not only a more efficient way to address social determinants of health in the workplace, but a more budget-friendly one...

Despite repeated calls for unity, democrats throw debate punches on health plans

Each candidate staked out a place on the health policy continuum but the biggest divide was between former Vice President Joe Biden — whose health care proposal includes a government-run...

FDA expert panel gives thumbs-up to Aimmune’s peanut allergy drug

The FDA’s Allergenic Products Advisory Committee voted 7-2 in favor of supporting the efficacy profile of Palforzia, or AR101. Some committee members expressed concerns about a lack of diversity in...

New startup aims to help investors avoid debacles through medical diligence

If they hope to grab a piece of the health-spending pie, investors and entrepreneurs may […] Source link

Groupons for medical treatment? Welcome to today’s U.S. healthcare

Groupon deals on healthcare such as chest CT or lung, heart and full-body scans are popping up across Atlanta, as well as in Oklahoma and California. Groupon also offers discount...

2019 is the year of the digital health IPO but will it last?

After a relatively quiet IPO market, 2019 has emerged as the year of the digital health IPO with Health Catalyst, Livongo Health, Phreesia, and Change Healthcare all going public and...

Another myeloma drug with same target as CAR-Ts shows successful Phase II results

Without providing details, GlaxoSmithKline said its trial of BCMA-targeting belantamab mafodotin was positive. The company plans to submit for regulatory approvals later this year – potentially ahead of bluebird and...

Trump officials look to ease privacy rules around addiction treatment records

Trump officials argue that current regulation has not kept up with the times and the necessity of coordinated approaches to addressing the opioid epidemic. Source link

Documents reveal conflict between VA and unelected Trump advisors

Marvel Chairman Isaac Perlmutter, lawyer Marc Sherman and physician Bruce Moscovitz – who have associated with President Trump through their membership in Trump’s Mar-a-Lago resort club – have formed an...

Dental company SmileDirectClub files to go public

The company offers personalized 3-D printed clear aligners – essentially a form of transparent plastic braces – in a direct to consumer model that it touts as cheaper and more...

FDA approves first drug for blood disorder myelofibrosis since 2011

The agency said Friday that it had approved Celgene’s Inrebic (fedratinib), the first new drug approved for the disease – a type of rare blood cancer – since the approval...

A majority of large employers want to expand Medicare, survey says

A recent survey from the National Business Group on Health found that among large employers, 55 percent were in favor of expanding Medicare. Source link

Exclusive: Director of TMC Venture Fund has been let go

Juliana Garaizar’s removal marks the second time in the past 12 months that TMC’s leadership is making executive changes at the very top of organizations under its umbrella that are...

Roche drug is third to win biomarker-driven cancer approval from FDA

On Thursday, Roche’s Rozlytrek won simultaneous FDA labels for NTRK fusion-positive solid tumors and ROS1-positive non-small cell lung cancer. Source link

CMS is bringing star quality ratings to health exchange plans

Rolling out the ratings nationwide is part of the Trump Administration’s larger initiative to inject cost and quality transparency into the healthcare system. Source link

Evidation Health and Eli Lilly study uses Apple wearables and apps to predict cognitive impairment

Early results from a study conducted by Evidation Health, Eli Lilly and Apple have shown the ability to detect cognitive decline and mild Alzheimer’s disease using a combination of Apple...

Doctors falsely argue plans to remedy surprise medical bills will ‘shred’ the safety net

The surprise medical bill legislation is an effort to help consumers who generally mistakenly thought they were getting health services covered by their insurers but instead find themselves dealing with...

Johnson & Johnson’s new antidepressant could face structural barriers to uptake

The FDA approved Spravato in March, but a new paper in JAMA examines some of the barriers inherent in the practice and reimbursement of psychiatry that could get in the...

Newsemia